Cytokinetics, Incorporated · NASDAQ:CYTK
Parshall B Lynne sold 5,000 Cytokinetics, Incorporated shares (Form 4)
Traded Sep 1, 2026 · Filed Sep 1, 2026
On Sep 1, 2026, Parshall B Lynne (Director) sold 5,000 Cytokinetics, Incorporated shares at US$71.48 for US$357K under a trading plan, leaving 10,784 shares. Filed Sep 1, 2026 (Form 4).
- Sold
- 5,000 shares
- Price
- US$71.48
- Value
- US$357K
- Holding after
- 10,784 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 1, 2026 | Common Stock | Sale | 5,000 | US$71.48 | 10,784 | Direct |
Source
Related
- Cytokinetics, Incorporated
- Parshall B Lynne
- Cytokinetics, Incorporated shareholders
- Form 4 · Parshall B Lynne · Jun 1, 2026
- Form 4 · Parshall B Lynne · May 27, 2026
- Form 4 · Malik Fady Ibraham · Oct 20, 2026
- Form 4 · Daly James M · Oct 20, 2026
- Form 4 · Henderson John T · Oct 20, 2026
- Form 4 · Wysenski Nancy · Oct 20, 2026
- Form 4 · Harrington Robert Arthur · Oct 20, 2026